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Background: Open lung biopsy (OLB) is helpful in the management of patients with acute respiratory
distress syndrome (ARDS) of unknown etiology. We determine the impact of surgical lung biopsies
performed at the bedside on the management of patients with ARDS.
Methods: We reviewed all consecutive cases of patients with ARDS who underwent a surgical OLB at
the bedside in a medical intensive care unit between 1993 and 2005.
Results: Biopsies were performed in 19 patients mechanically ventilated for ARDS of unknown
etiology despite extensive diagnostic process and empirical therapeutic trials. Among them, 17 (89%)
were immunocompromised and 10 patients experienced hematological malignancies. Surgical biopsies
were obtained after a median (25%-75%) mechanical ventilation of 5 (2-11) days; mean (±SD) PaO2/
FiO2 ratio was 119.3 (±34.2) mm Hg. Histologic diagnoses were obtained in all cases and were specific
in 13 patients (68%), including 9 (47%) not previously suspected. Immediate complications (26%) were
local (pneumothorax, minimal bleeding) without general or respiratory consequences. The biopsy
resulted in major changes in management in 17 patients (89%). It contributed to a decision to limit care
in 12 of 17 patients who died.
Conclusion: Our data confirm that surgical OLB may have an important impact on the management of
patients with ARDS of unknown etiology after extensive diagnostic process. The procedure can be
performed at the bedside, is safe, and has a high diagnostic yield leading to major changes in
management, including withdrawal of vital support, in the majority of patients.
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123Impact of bedside open lung biopsies1. Introduction bilateral infiltrates on chest x-ray, and a pulmonary capillaryAcute respiratory distress syndrome (ARDS) is a frequent
cause of long duration of mechanical ventilation in critically
ill patients [1]. Guidelines for the management of this
syndrome include the identification of all possible causes
susceptible to benefit from a specific treatment [2,3].
Nevertheless, despite an extensive diagnostic process,
including sophisticated imaging techniques (high-resolution
computed tomodensitometry, nuclear magnetic resonance,
positron emission tomography) and microbiology (cultures,
serology-based and polymerase chain reaction–based detec-
tion of microorganisms in the blood or in specimens obtained
through bronchoalveolar lavage [BAL]), the etiology of
ARDS remains unknown in 5% to 10% of patients [4,5].
In worsening ARDS of unidentified cause, many
clinicians empirically combine broad spectrum antimicrobial
agents with immunosuppressive therapy as steroids, and the
impact of such potentially contradictory strategies may itself
contribute to worsen the prognosis [6,7]. In this situation,
lung tissue histologic examination may be useful, particu-
larly in immunocompromised patients as suggested from
older series [8,9]. Hence, surgical biopsy is a recognized
accurate diagnostic method for diffuse lung disease in
immunocompetent patients [10]. In patients with respiratory
distress, many authors suggest that surgical open lung
biopsies (OLBs) can be performed safely with a high
diagnosis yield [11,12], even if the they have hematologic
diseases [13]. Papazian et al [14] reported in 1998 a very low
rate of complications and suggested that such procedure may
be performed at the bedside.
We reviewed specifically our local surgical OLBs
performed at the bedside of patients with ARDS of unknown
etiology after extensive diagnostic process and requiring
mechanical ventilation for persistent respiratory failure
despite aggressive empirical treatments. The scope was to
evaluate whether that procedure had brought an impact on
the management or treatment decision in these patients.
2. Patients and methods
We identified retrospectively all patients hospitalized in
the medical intensive care unit (ICU) of our institution with
ARDS who underwent a bedside surgical OLB between
1993 and 2005. This unit is a tertiary and teaching hospital
with 1500 beds, with an average of 1500 admissions every
year for a median length of stay of 3 days. The ethical
committee of the institution approved the extraction of data
from the medical charts. Potential cases were identified
through a review of the operative protocols of the thoracic
surgery and completed by an electronic search in the
database of the Department of Clinical Pathology. Patients
with documented ARDS were then included. Acute
respiratory distress syndrome was defined as brutal onset
event, severe hypoxemia (PO2/FiO2 ratio, b200 mmHg), withwedge pressure of less than 18 mm Hg, or no evidence of
heart failure on echocardiography [15].
2.1. Extraction of the data
Data extracted from the medical records and files were
demographic characteristics, reason for admission, under-
lying diseases, operation report, and histology from lung
biopsies. We also extracted characteristics of eventual organ
failures, parameters of mechanical ventilation, oxygenation
parameters, and catecholamine requirements on the day of
surgery for lung biopsy. All diagnostic procedures performed
before the biopsy were recorded (cellular characteristics of
BAL; imaging documents; complete available microbiolo-
gical information, including serology). We then look at
potential local complications related to surgery (air leak,
pneumothorax, and bleeding) and at the impact on the
management of the patients after biopsy.
2.2. Surgical procedure and histology analysis
The surgical lung biopsy was carried out at the patient's
bedside in the intensive care unit by 2 surgeons. Anesthesia
was provided by midazolam or propofol, combined with
sulfentanyl, completed by nondepolarizing neuromuscular
blocking agents. All patients were mechanically ventilated
for their respiratory failure, through an orotracheal low-cuff
pressure single-lumen tube. The orotracheal tube used in
every patient was not changed, that is, for a selective
bronchial intubation device. When pulmonary infiltrates
were bilateral and homogeneous, preference was given to a
left-sided approach for a resection of the tip of the lingula as
described by Miller et al [16].
The axillary-anterior incision, approximately 5 cm long,
was carried out under the breast, to gain access to the upper
edge of the sixth rib. When present, pleural fluid was
collected for bacteriologic and/or cytologic purposes. The 2
adjacent ribs were kept apart with a retractor. The tip of the
lingula was then exteriorized and resected with a mechan-
ical GIA-type stapler, the ventilator being disconnected
during the stapling. The piece of lung retrieved was sent for
extensive microbiological and pathologic examinations, the
latter like a frozen section. A single chest tube was
introduced into the pleural cavity through the incision itself,
and the incision was closed in 3 layers with resorbable
material (including the skin). The whole procedure took 30
to 45 minutes, and the chest tube was removed a couple of
days later, after having checked for the absence of any air
leak and/or excessive fluid output (N150 mL/d). Biopsies
were analyzed within 24 to 48 hours from a pathologist
with expertise in lung diseases. All cases were discussed in
a multidisciplinary meeting that included intensivists,
pathologists, surgeons, pneumologists, and infectiologists
or onco-hematologists, and additional tests were performed
when appropriate.
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Of 54 patients who underwent a surgical lung biopsy in
the institution, 19 open biopsies were performed in the
medical ICU at the bedside for ARDS between 1993 and
2005. The 19 patients represented around 8% to 10% of all
ARDS and their characteristics at the time of biopsy are
summarized in Table 1. As described in Table 2, a majority
(89%) of the patients were immunocompromised and many
received long-term corticosteroids. Two patients were not
immunosuppressed and developed an ARDS after cardiac
and plastic surgery, respectively. All patients received broad
spectrum antimicrobials for suspected infection.
The diagnostic workup performed before selection for a
bedside surgical OLB is listed in Table 3. All but one patient
had a bronchoscopic BAL 2 to 5 days before the biopsy, with
systematic analysis of cellular content and extensive micro-
biological workup. Cellular content was nonspecific and
microbiological results were negative in all cases. Two
polymerase chain reaction procedures performed on material
obtained from BAL gave false-positive results (Pneumocystis
jiroveci, herpes simplex virus), not confirmed by culture and/
or the biopsies. All patients had a high-resolution computed
tomography of the lung, which revealed nonspecific diffuse
interstitial involvement with various degrees of alveolar
involvement in all cases.
The biopsy was performed at the lingula in 12 patients
(63%), at the right lower lobe in 4 (21%), and in 3 others at
the left lower lobe, the right middle lobe, and the right upper
lobe, respectively. Other locations than lingula were chosen,
either for technical reasons or because of more dense opacity.
Histology obtained from biopsies are summarized in Table 4.
Biopsies resulted in a histologic diagnosis in all patients. ATable 1 Characteristics of the patients at time of the
surgical OLB
Characteristics
Age (y), mean ± SD 50 ± 15
Male sex, n (%) 11 (57.9)
Patients under immunosuppressive
treatment before the biopsy, n (%)
17 (89.5)
Neutropenic patients, n (%) 7 (36.8)
Empirical broad spectrum antibiotic, n (%) 19 (100)
Antifungal therapy, n (%) 8 (42.1)
Antiviral therapy, n (%) 4 (21.1)
Organ system failure, median (25%-75%) 2 (2-3)
PaO2/Fio2 ratio (mm Hg), mean ± SD 119.3 ± 34.2
PEEP the day of biopsy (cm H2O), mean ± SD 6 ± 3
Duration of mechanical ventilation before
the biopsy (d), median (25%-75%)
5 (2-11)
Total duration of mechanical ventilation (d),
median (25%-75%)
11(5-31)
Vasopressor requirement before the biopsy, n (%) 14 (73.7)
Surgical open biopsy of the lingula, n (%) 13 (68.4)
PEEP indicates positive-end expiratory pressure.specific diagnosis was reached in 13 patients (68%), which
was not previously suspected in 9 patients (47%). Nine
patients had a diagnosis of diffuse alveolar damage, with
evidence of a fibroproliferative stage in 4 of them. An
unspecific diagnostic procedure was made in 6 patients
(32%). The lingula gave a similar yield of specific diagnosis
compared to other sites (66% vs 57%).
An infection was documented in 7 cases: cytomegalo-
virus in 4, hematogenously spread disseminated Candida
albicans, and P jiroveci pneumonia which was negative on
BAL performed 2 days before surgery in each, respectively.
A respiratory syncytial virus grew from culture of the biopsy
in an additional case initially scored as nonspecific
pneumonia compatible with a viral infection. No bacteria
grew from culture of the tissue except a small amount of
coagulase-negative Staphylococcus in 1 case which was
interpreted as a contaminant.
3.1. Impact of the biopsies on the treatment of
the patients
The impact of the biopsies on the treatment of each patient
is listed in Table 4. Biopsies resulted in changes (simple or
multiple) in the treatment in 17 patients (89%), as
summarized in Table 5. The treatment was not changed in
only 2 patients. One patient with histology of diffuse alveolar
damage, corresponding to the exsudative phase of a
secondary ARDS. The other patient died before the
identification of an unexpected P jiroveci pneumonia for
which a specific treatment could not be given.
3.2. Outcome
Only 2 patients (11%) could be weaned from mechanical
ventilation and were discharged alive from the ICU (Table 4).
The median of total duration of mechanical ventilation was
11 (5-31) days. Fourteen of the 17 patients who died
developed persistent multiple organ failure or unresponsive
hypoxemia. The median time (range) between lung biopsies
and death was 10 (3-27) days.
However, only 5 died from organ failure that did not
respond to maximal treatment. The biopsy resulted in a direct
withdrawal of vital support in 3 patients owing to the
reported diagnosis (severe lung fibrosis in 2 and carcinoma-
tous lymphangitis in 1) among the context of worsening
critical state of the patient. It resulted in a main contribution
to the decision to limit the extent of the care in 9 additional
patients, and all ultimately died from further withdrawal of
vital support.
3.3. Adverse effects of surgery
Local complications developed after surgery in 5 patients
(26%). A pneumothorax requiring the insertion of an
additional chest tube developed in 2 patients, and surgery
Table 3 Diagnostic workup before biopsy
Type of investigation No. of patient (%)
Bronchoscopic BAL 18 (94.7)
Transbronchial biopsy 1 (5.2)
BAL cell content examination 18 (94.7)
Lung fluid b and blood microbiology 19 (100)
Fungi and parasites search 19 (100)
PCR a for respiratory viruses in BAL 3 (15.8)
Computer tomography 19 (100)
a Polymerase chain reaction, introduced in 2002.
b Bronchoalveolar lavage or tracheal aspiration.
Table 2 Immunosuppression description a
Patient
(sex [F/M]; age [y])
Main underlying diseases
at ICU admission
Immunosuppressive therapy before
development of the ARDS
1. (F; 41) Acute myeloid leukemia, M5 type Bone marrow transplantation,
cyclosporine, neutropenia
2. (M; 54) Acute myeloid leukemia, M6 type Bone marrow transplantation, neutropenia
3. (M; 17) Acute biphenotypic leukemia Bone marrow transplantation, neutropenia
4. (M; 46) Clinical suspicion of idiopathic lung fibrosis High-dose corticosteroids, chronic alcoholism
5. (F; 66) Goodpasture syndrome High-dose corticosteroids, cyclophosphamid
6. (M; 58) Lung transplantation 22 months ago Tacrolimus, mycophenolate, and corticosteroids
7. (M; 47) Epidermoid carcinoma of the esophagus Corticosteroids for late phase of a
postoperative ARDS
8. (F; 63) Liver cirrhosis (hepatitis C) and sarcoidosis Long-term corticosteroids
9. (M; 22) Acute myeloid leukemia, M4 type Bone marrow transplantation, corticosteroids
10. (M; 49) Hodgkin disease, stage IIA Induction chemotherapy, neutropenia
11. (M; 52) Aplastic anemia Autologous stem cell
transplantation, cyclosporine, neutropenia
12. (M; 45) Clinical suspicion of idiopathic lung fibrosis High-dose corticosteroids
13. (F; 41) Chronic myeloid leukemia, granulomatosis Bone marrow transplantation, cyclosporine,
neutropenia
14. (F; 67) Plastic surgery (after breast cancer) None
15. (F; 66) Hodgkin disease, stage IVB High-dose corticosteroids
16. (M; 69) Cardiac surgery (valve replacement None
17. (F; 73) Hodgkin disease, stage IVB Induction chemotherapy, neutropenia, corticosteroids
18. (F; 52) Paracolic abscess (actinomyces) Corticosteroids for 2 wks
19. (M; 39) Acute myeloid leukemia, M2 type Bone marrow transplantation,
tacrolimus, mycophenolate
M indicates male; F, female.
a For patients 5, 6, 9, 12, 15, and 17, corticosteroids were part of the treatment of the underlying condition. They were empirically started for the current
episode of acute respiratory failure in patients 4, 7, and 12.
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loss of more than 200 mL required transfusion in 2 patients
of 4 and 3 U of red cells, respectively. These 2 patients also
sustained a thrombopenia before the biopsy, and both
required additional hematologic support by transfusion of 2
and 4 U of thrombocytes, respectively. No patient required
transfusion of fresh frozen plasma.
4. Discussion
Our data confirm that surgical OLB for ARDS of
unknown etiology is safe and may provide important
information susceptible to induce major changes in the
management of these patients. This has already been
previously suggested by several series, including in
immunocompromised patients in whom empirical treatment
of all potential etiologies may be detrimental [11-14,17] and
in early-stage ARDS of suspected noninfectious origin [18].
In addition, despite many theoretical advantages and
encouraging preliminary reports, transbronchial biopsies
may not represent a good alternative to surgical OLB in
severely ill ventilated ARDS patients [19-21].
A particular interest of our small retrospective series is
that all biopsies have been performed in the ICU at the
bedside of mechanically ventilated patients. This allowed usto avoid moving these patients to the operative room, a
procedure known to be associated with potential important
morbidity in critically ill patients [22].
The biopsy resulted in major change in the management
of 17 (89%) of the 19 patients. This finding is consistent with
those of previous reports and emphasizes the usefulness of
surgical OLBs in worsening ARDS [11,13,14,23,24]. We
observed a very high mortality rate (89%), due to multiple
organ disorders of the patients and the severity of their
organic damage. However, and more importantly, the fatal
issue resulted from a decision to limit the extent of the care
directly related to the result of the biopsy in 12 patients,
including a rapid withdrawal in 3 of them. Accordingly, the
Table 4 Histology obtained from surgical OLBs: impact on treatment and final outcome
Patient
(sex [F/M]; age [y])
Site of
biopsy
Histologic finding
of the lung biopsy
Complications
of the biopsy
Modifications in treatment
according to the results
of the biopsy
Outcome,
cause of death
1. (F; 41) Right
upper
lobe
Pneumonia due to
Pneumocistis jiroveci
Pneumothorax No, dead before results Death, day 2 right
heart failure
2. (M; 54) Right
lower
lobe
Diffuse alveolar damage;
cytomegalovirus infection
None Yes, start of gancyclovir
and broad spectrum
antibiotics stopped
Death, day 4
CNS hemorrhage
3. (M; 17) Lingula Cytomegalovirus infection None Yes, start of gancyclovir
and broad spectrum
antibiotics stopped
Death, day 24 a
multiple organ failure
4. (M; 46) Lingula Diffuse carcinomatous
lymphangitis
None Yes, withdrawal of vital support Death, day 2
refractory hypoxemia
5. (F; 66) Lingula Cytomegalovirus infection Hemorrhage Yes, start of gancyclovir and
high-dose corticosteroids stopped
Death, day 2 a
multiple organ failure
6. (M; 58) Right
middle
lobe
Acute rejection grade A3
(bronchiolitis obliterans)
None Yes, start of high dose of
corticosteroids
and of cyclosporine
Survival, discharged
on day 10
7. (M; 47) Lingula Hematogenous abscesses
(Candida albicans)
None Yes, start of amphotericine B
and corticosteroids stopped
Survival, discharged
on day 28
8. (F; 63) Lingula Diffuse alveolar damage in
fibroproliferative phase
Hemorrhage Yes, increase of corticosteroids
and broad spectrum
antibiotics stopped
Death, day 10 a
multiple organ failure
9. (M; 22) Lingula Histologic damage related
to busulfan toxicity
None Yes, increase of corticosteroids
and broad spectrum
antibiotics stopped
Death, day 10 a
refractory hypoxemia
10. (M; 49) Lingula Diffuse alveolar damage;
in exsudative phase
None Yes, broad spectrum
antibiotics stopped
Death, day 46 a
multiple organ failure
11. (M; 52) Right
lower
lobe
Diffuse alveolar damage;
in fibroproliferative phase
None Yes, increase of corticosteroids
and broad spectrum antibiotics
stopped
Death, day 33 a
multiple organ failure
12. (M; 45) Lingula Diffuse alveolar damage;
in fibroproliferative phase
None Yes, adaptation of corticosteroids
and broad spectrum antibiotics
stopped
Death, day 34
refractory hypoxemia
13. (F; 41) Right
lower
lobe
Diffuse alveolar damage;
in exsudative phase; TE
None Yes, start of defibrotid
(Prociclide, Crinos SpA,
Milan, Italy) b and broad
spectrum antibiotics stopped
Death, day 33
cardiac arrest
14. (F; 67) Lingula Histologic pneumonia
with viral inclusions
None Yes start of ribavarin Death, day 33 a
refractory hypoxemia
15. (F; 66) Lingula Lung fibrosis related to
toxicity of bleomycine
None Yes, withdrawal of vital support Death, day 3
refractory hypoxemia
16. (M; 69) Left
lower
lobe
Diffuse alveolar damage;
in exsudative phase
None No Death, day 1 multiple
organ failure
17. (F; 73) Lingula Lung fibrosis related to
toxicity of bleomycine
Pneumothorax Yes, adaptation of
corticosteroids and broad
spectrum antibiotics stopped
Death, day 7 a
multiple organ failure
18. (F; 52) Right
lower
lobe
Diffuse alveolar damage;
cytomegalovirus infection
Surgical air
leakage
Yes, start of gancyclovir and
corticosteroids stopped
Death, day 36 a
refractory hypoxemia
19. (M; 39) Lingula Diffuse alveolar damage; in
fibroproliferative phase
None Yes, withdrawal of vital support Death, day 8
refractory hypoxemia
CNS indicates central nervous system; TE, thromboembolia.
a Limitation of the extent of the care, ultimately contributing to withdrawal of vital support.
b For liver veno-occlusive disease.
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Table 5 Changes in treatment
Changes No. of patient (%)
New anti-infectious therapy 5 (26.3)
New immunosuppressive therapy 3 (15.8)
Unnecessary antibiotics stopped 8 (42.1)
Corticosteroids stopped 3 (15.8)
Change of corticosteroids dosage 4 (21.1)
Withdrawal of supportive therapy 3 (15.8)
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patients who ultimately died as a consequence of their ARDS
and multiple organ failure.
The 19 patients of the present series were relatively
homogenous. All sustained severe forms of ARDS.
Extensive diagnostic workup was negative in all of them,
and biopsy was only decided after trials of empirical
treatments, including broad spectrum antimicrobials and
steroids for those suspected to be in the fibroproliferative
phase of ARDS [25].
Despite the severity of the ARDS, the procedure was safe.
Respiratory failure did not worsen owing to the surgical
biopsy. We observed only 5 local complications (26%), and
new surgery for persistent air leakage was required in only 1
patient. These findings are comparable with those of the
literature which reported occurrences in 15% to 25% of cases
[26,27]. It is possible that pneumothorax might be avoided
by using 2 chest tubes instead of 1. No patient died as a
consequence of surgery, and no change in vasopressor use or
immediate oxygenation need was observed. Early death
observed in patients 1 and 16 could have been related to the
procedure, but no change in intrathoracic pressures or
mechanical ventilation was noticed.
Several limitations may limit the extent of the information
we can draw from our data. Our small series is not
representative of the population sustaining ARDS, but only
of a particular subgroup in a majority of immunocompro-
mised patients carefully selected by a multidisciplinary team
after negative extended diagnostic assessment and empirical
treatments. In contrast to other series [11,14], all our patients
were treated with broad spectrum antibiotics at the time of
microbiological sampling by BAL, which may have resulted
in a lower sensitivity of these examinations. However, none
of our patients responded to empirical treatments and, except
one hematogenous disseminated candidiasis, the biopsies did
show unsuspected infection in 6 patients.5. Conclusion
Surgical OLBs may be safely performed at the bedside of
mechanically ventilated patients with ARDS of unknown
etiology after extensive diagnostic process and despite
empirical therapeutic trials, particularly if they are immuno-
compromised. The procedure is associated with a highdiagnostic yield leading to specific modifications of the
management of the patients, including withdrawal and
limitation of futile care in a majority of them.References
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